Developing alternative devices to the long-term urinary catheter for draining urine from the bladder by Feneley, R.C.L. et al.
297
Special Issue Paper
Developing alternative devices to the long-term urinary
catheter for draining urine from the bladder
R C L Feneley1*, J Parkin1, J Scanlan2 and M Woolley2
1Southmead Hospital, Westbury-on-Trym, Bristol, UK
2Faculty of Engineering, University of West England, Bristol, UK
Abstract: The self-retaining urinary catheter is used for long-term drainage of urine from the bladder
only as a last resort because of serious associated complications, yet it remains a routine method for
managing older and disabled patients with loss of bladder control. Blockage of the catheter from
calci￿ed deposits within its lumen is a common occurrence, obstructing the passage of urine and
causing an urgent, unpredictable problem for patients, carers and the nursing sta￿ . The need for
further research on the subject has been recognized for many years. The SuPort Project aimed to
develop an alternative suprapubic urine collection system. This report outlines the approach adopted
towards the design and selection of the novel device, the production problems that ensued and the
small clinical trial of a modi￿ ed prototype.
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1 INTRODUCTION
New product development starts with the recognition of
need to address a problem. The self-retaining balloon
catheter was ￿ rst described by Foley in 1929 as ‘a hemo-
static bag catheter’ for use following cystoscopic prostat-
ectomy, a new operation that he introduced [1]. In 1937,
Foley reported a modi￿ ed self-retaining bag catheter,
made of latex, for constant drainage of urine from the
bladder [2]. Since then, the basic design of the catheter
has not changed, and concerns have arisen regarding the
risks of allergy to latex. Di￿ erent materials have been
used for catheter manufacture in an attempt to reduce
catheter encrustation at the urine/biomaterial interface.
The self-retaining urinary catheter is employed univer-
sallyfor short-term or long-term drainage of the bladder,
in males and females (Fig. 1).
The catheter can be passed either via the urethra, the
natural passage into the bladder, or via the suprapubic
route, a direct arti￿ cial tract through the lower abdomen
above the mid-line symphysis of the pubic bone.
Urethral catheterization is normally simple to perform,
but repeated catheterization over the long term risks
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Fig. 1 Conventional urinary catheter with the self-retaining
balloon distended
injury or infection to the urethra. In women with neuro-
logical conditions such as multiple sclerosis, the catheter
can be expelled spontaneously with the balloon dis-
tended, causing distension and damage to the urethra;
in men, periurethral infection can result in serious com-
plications. The initial introduction of the suprapubic
catheter involves a minor operative procedure, normally
performed under a local anaesthetic; once the tract into
the bladder is established, the catheter can be changed
readily. Suprapubic catheterization is considered prefer-
able for nursing those who are bedbound or in wheel-
chairs, and it is more acceptable for those who wish to
remain sexually active.298 R C L FENELEY, J PARKIN, J SCANLAN AND M WOOLLEY
Catheterization of the bladder with drainage of urine
into a bag provides the most practical and reliable means
of collecting and containing the urinary output from
patients with loss of bladder control; the total urinary
output of an individual normally ranges from 1000 to
1500 ml/day. For those who are cognisant and have good
manual dexterity, the bladder may be emptied intermit-
tently by ￿ tting the catheter with a valve. Alternatives
to the catheter consist of disposable incontinence pads,
worn as a diaper, or the external penile sheath appliance
for the male. Incontinence pads have a limited capacity
and are di￿ cult to maintain in position, so leakage is
common. The condom appliance in the male can be
di￿ cult to apply and has a propensity to fall o￿ the
penis in older men. None of these devices is discreet, and
none presents an attractive alternative to patients.
Long-term use of the catheter, for 28 days or longer,
is associated with chronic bacteriuria and a high mor-
bidity which has been recognized for many years [3–6].
Apart from trauma, urinary infection accounts for vir-
tually all the complications associated with long-term
catheterization (LTC), including bacteraemia, catheter
blockage, bladder stones, periurethral infections, pyelo-
nephritis, septicaemia, bladder cancer and death [7]. A
prospective study of a population of nursing home resi-
dents established that, whatever their medical status in
relation to age, such as heart disease, diabetes or cancer,
catheterized patients were 3 times more likely to die
within a year than non-catheterized patients [8]. Up to
40 per cent of all nosocomial infections are associated
with catheterization, accounting for over 1 million infec-
tions in US hospitals per annum [9]. Urethral catheter-
ization initiates bacteriuria at a rate of 3–10 per cent/
day, and within 4 weeks virtually all bladders will be
colonized [10]. If urease-producing organisms are pre-
sent, urea is hydrolysed to ammonia and carbon dioxide,
the urine becomes alkaline and crystals of calcium phos-
phate and ammonium magnesium phosphate nucleate
on the catheter surface, causing obstruction to urine
drainage and bladder stones [11]. Many di￿ erent mate-
rials have been used for catheter manufacture in an
attempt to reduce surface encrustation, but, as yet, cur-
rently available types of catheter material have all been
shown to be vulnerable to bacterial colonization and
encrustation [12]. Encrustation leads to blockage of the
catheter, and recurrent blockage is associated with a high
incidence of bladder stones; up to 50 per cent of patients
with LTC experience episodes of catheter blockage at
unpredictable times, day or night, requiring urgent atten-
tion [13]. The routine care of these patients, including
catheter changes every 6–12 weeks and unplanned
emergency calls, occupies an estimated 4 per cent of
District Nursing workload [14, 15].
In summary, the long-term use of urinary catheters
is associated with a high morbidity, and the need
to research and develop improved methods of urine
collection has been recognized for many years.
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1.1 The SuPort Project
The SuPort Project (M54), funded by the MedLINK
programme, involved a multidisciplinary partnership
between the North Bristol NHS Trust, as the clinical
centre, the Faculty of Engineering at the University of
the West of England, as the academic support, and
two industrial partners, namely EMS (Medical) and
KeyMed (Medical and Industrial Equipment) Limited.
During the course of the ￿ rst year,the urological division
of EMS (Medical) was transferred to Seton, which later
became SSL International. The project started on
1 September 1997 and ended on 31 August 2001.
The project set out to design and develop an alterna-
tive suprapubic urine collection system for long-term use
with the following features:
(a) a suprapubic port providing e￿ cient drainage of
urine either continuously into a bag or, if appro-
priate, intermittently when necessary (Fig. 2). It was
to be more aesthetic than the catheter and easier for
the patient or carer to manage in the event of any
complication such as blockage;
(b) an irrigation/drainage catheter that could be passed
through the port by the patient or carer to clear any
blockage from encrustation and to remove calci￿c
debris from the bladder, thus reducing the risk of
possible bladder stone formation;
(c) access for endoscopic examination for inspection
and removal of bladder stones.
The clinical team envisaged a device that would allow
the patient or carer to be as independent as possible of
routine nursing supervision. The medical/nursing team
would be responsible for introducing the device into the
bladder and changing it at regular six monthly intervals,
but the routine weekly maintenance and hygiene would
be undertaken by the patient or carer.
An alternative retention mechanism to the balloon
of the conventional Foley catheter was considered
Fig. 2 Concept of a suprapubic device providing continuous
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preferable. The balloon provides a large surface area for
bio￿ lm and crystalline deposits, and the size of the
internal lumen of the drainage channel is compromised
by the presence of a balloon-￿ lling channel in the wall
of the catheter. Moreover, the tip of the catheter with
the drainage eyes protrudes beyond the balloon so that
stagnant urine remains in the bladder base when the
catheter is placed in the urethra and can cause trauma
to the bladder wall if passed suprapubically.
2 METHODS AND MATERIALS
The engineering design method to be adopted for the
suprapubic port presented a major challenge owing to
the multiple criteria that had to be considered, including
clinical, microbiological, material science and aesthetic
factors. A method was required that would address the
selection of alternatives when such a variety of needs
was presented. An evaluation of practical applications
of systematic engineering design techniques was under-
taken, and an established method of ‘design through
selection’ was studied, involving a two-stage approach
[16]. The design process starts with an agreed list of
criteria or ‘attributes’ as they are called. During the ￿ rst
phase, a large number of concepts are generated, and
from these a preliminary selection is made of the alterna-
tives most likely to succeed. These then pass into the
second phase, forming the input to a selection-decision
support problem (selection-DSP). The selection-DSP
uses insight-based ‘soft’ and science-based ‘hard’ infor-
mation to evaluate and rank the feasible alternatives in
order of preference, using the established attributes. The
highest ranking design is submitted to detailed analysis
(Table 1).
This design method of formulating selection-DSPs
was enhanced by introducing quality function deploy-
ment (QFD) as an auxiliary technique to identify attri-
butes produced via the initial QFD matrix [17]. QFD
focuses on developing products in response to customer-
de￿ ned criteria by collating ‘customer’ against the neces-
sary ‘technical’ requirements. Customer requirements
are ￿ rst identi￿ ed and listed on the left or vertical axis
of a ‘house of quality’ matrix and given a value of rela-
tive importance from 1 to 5. Each item is then broken
down into technical attributes to meet the customer
Table 1 Design through selection
Phase 1. Generation and Phase 2. Formulation and
identi￿cation of potentially solution of selection-DSP
feasible concepts
Recognition of need Identi￿cation and ranking
Generation of concepts of attributes
Preliminary selection of Evaluation of alternatives
feasible concepts Ranking of alternatives
Post-solution analysis
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requirements and listed on the upper horizontal axis
above the central matrix; a relationship value, strong,
medium or weak, is then assigned between customer and
technical requirements within the matrix. On the lower
horizontal or ‘how much’ axis of the matrix, the relative
importance of each technical requirement is indicated by
summation of the customer importance value and
relationship value. This guides the designers so that
product development is focused towards the previously
identi￿ ed customer requirements. The approach to the
design by the engineering team was thus structured to
form a robust, two-phase, systematic process for the
research and development of the suprapubic port [18].
2.1 Phase 1. Generation and identi￿cation of potentially
feasible design alternatives
The need for an improved method of permanent bladder
drainage had been established as outlined in section 1.
To establish ‘customer’ requirements, several group
meetings were held, involving members of the partner-
ship with patients, carers and district nursing sta￿ . These
led to the formulation of a ‘product design speci￿ cation’,
a list of general design requirements aimed at overcom-
ing some of the problems associated with LTC. To this
were added clinical pass/fail criteria, which listed poten-
tial failure modes and the level of risk these might have
of morbidity or threat to life. New design concepts were
generated by holding brainstorming meetings within the
partnership, where ideas and possible solutions were
recorded in morphological chart form, producing many
possible alternatives. These were each compared with a
standard (the Foley catheter), using criteria chosen from
the design speci￿cation, to identify the options most
likely to succeed or ‘feasible design alternatives’.
2.2 Phase 2. Formulation and solution of a
selection-DSP and post-solution analysis
‘Customer’ requirements were prioritized and then used
in a QFD matrix to identify and rank design attributes.
This produced a ranking of the speci￿ c design attributes
in order of importance that could be used for selecting
from the alternatives available. The model can then
determine the relative importance of customer require-
ments together with the ranked design attributes. The
feasible design alternatives identi￿ ed in phase 1 are thus
mathematically tested to predict the most suitable
option. Since the outcome may be sensitive to minor
changes in the ￿ gures, the ￿ nal step involves
re-examining the calculations, relative weights and
ratings to verify the selection.
Medical devices are developed in line with current
good design practice (cGDP), with attention to the
constraints of the Federal Drug Agency (FDA) and
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adopted structured approach ensured justi￿ cation of
the design processes with validation and veri￿cation
of design, design requirements, risk management,
manufacturing methods and test apparatus.
3 RESULTS
3.1 Design
3.1.1 Phase 1. Development of feasible design
alternatives
The initial meetings of the multidisciplinary team with
patients, carers and nurses in phase 1 established two
lists of ‘customer’, namely patient and medical team
requirements (Table 2). From these were developed a set
of key design parameters that any product must contain
in order to ful￿ l these demands. At an early stage it was
decided the device presented two semi-independent
design areas, the ‘bladder retention mechanism’ and the
‘external skin ￿ ange’, which would be developed in
parallel.
The bladder retention mechanism generated a large
number of concepts, but these relied heavily on the
mechanical properties of a limited range of FDA/MDD-
approved biocompatible materials. Preliminary selection
produced three alternatives ‘most likely to succeed’,
namely the stretched dome, the tension cage and the
drawcord lantern (Fig. 3) which were tested prior to
passing into phase 2 of the design process. The designs
were validated with respect to the benchmarked bladder
retention force of the self-retaining balloon or Foley
catheter. A novel anatomical model was constructed for
measurement of the retention force of the Foley catheter
[19], which was found to be 30 N. This was considered
to be in excess of the retention force necessary to avoid
Table 2 ‘Customer’ requirements
Patient Requirements Medical team Requirements
Comfort Short/long term Maintenance Easy to replace and irrigate
Least amount of discharge Emergency removal possible
Little interference with Little maintenance
mobility/sleep/clothing Low replacement frequency
Good access to bladder
Appearance Acceptable size/colour/shape/ Application Any abdominal wall thickness
feel/texture All ages and bladder dimensions
Any patient condition and size
Reliability Low frequency of replacement Surgical Short and easy insertion time
Low risk of leakage factors Few skills and facilities needed
Easy to replace to insert
Low risk of infection
Complications Low risk of blockage/ Performance Little valve or urethral leakage
infection/stones/bleeding Good ￿xation
Ease of use Ability to locate and grip Inspection Easy to inspect
drainage tube easily Wide coverage of inspection
Easy to clean
Quick to empty
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Fig. 3 Alternative designs for the retention mechanism: the
stretched dome, the tension cage and the drawcord
lantern
inappropriate extraction, and a retention force of 21 N
(66 per cent) was accepted as the target for the new
device.
The stretched dome design is so called because the
dome is stretched over a metal trocar to reduce its diam-
eter for introduction through the suprapubic tract into
the bladder; it was assessed using ￿ nite element analysis.
This indicated that the force required to deploy the dome
would result in the failure of the reinforcing ring (Fig. 3).
The concept was ￿nally rejected because the material
properties of those certi￿ ed by the FDA were inadequate
to prevent the ring from bursting from the dome during
the clinical insertion.
The tension cage was prepared by utilizing computer
generated three-dimensional modelling, rapid proto-
typing (stereolithography) and injection moulding tech-
nology. Observations from inspection and handling
alone clearly indicated that the cage did not possess
an adequate bladder retention force, and this was thus
rejected.
Thus, of the three alternatives, only the drawcord
lantern was found to be functionally sound, and there-
fore this was chosen without further analysis by
selection-DSP. The design underwent a number of modi-
￿ cations (including increases in the Young’s modulus,
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Table 3 Ranked ‘customer’ requirements (selected)
Relative Relative
importance Patient importance Medical team
23 Leakage risk 27 Ability to remove in emergency
20 Quick to empty 25 Positive ￿xation
20 Resistance to stone formation 22 Ease of replacement
19 Ability to clean easily 21 Initial surgical skills required
16 Ability to grip drain/irrigation tube 20 Low risk of surgical infection
15 Replacement frequency 19 Ease of surgical insertion
13 Interference with clothing 16 Good access to bladder
8 Interference with mobility 13 Tract leakage
8 Minimization with infection 12 Valve leakage
3 Colour 5 Maintenance facilities required
2 Shape 1 Maintenance time required
1 Surface texture 0 Initial surgical time required
optimize the retention force of the lantern. However,
bench tests using the anatomical model quanti￿ ed a
repeatable retention force of only 10.5 N, which was half
the benchmark ￿ gure, thus raising the question as to
whether this would be adequate to avoid the risk of the
port being inadvertently pulled out of the bladder.
The skin ￿ ange of the port was designed to be lozenge
shaped to avoid sharp edges which could cause skin
ulceration when the subject moved from the lying to the
sitting position. Construction was designed to be in two
parts to maximize indwelling duration. One section of
the ￿ ange, the port assembly, formed the external part
of the indwelling port and rested on the skin surface;
this was expected to remain in situ for at least 6 months.
The other section, the valve assembly, was a removable,
replaceable cap that included a valve for intermittent or
continuous drainage of the bladder.
3.1.2 Phase 2. Optimal selection and post-solution
analysis
To select the optimal design for the skin ￿ange from the
feasible alternatives, patient and medical team require-
ments were ranked in order of relative importance and
used in a QFD matrix to demonstrate how the design
attributes ranked against ‘customer’ requirements.
Examples of the ranking of customer requirements are
given in Table 3, where a higher number denotes greater
perceived importance.
Table 4 gives a selection of the design attributes in
order of relative importance generated from the QFD
matrix. The higher the number, the more important this
design attribute is to ful￿ l the speci￿ ed customer require-
Table 4 Examples of relative importance
of design attributes
Design attribute Score
Duration (working life) of port 0.545
Flowrate (valve and drainage tube) 0.494
Ease of valve replacement 0.430
Interference with mobility 0.191
Level of dexterity required 0.143
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ments. Table 5 shows how the feasible design alternatives
ranked against the ‘customer’ requirements.
Design alternative 5 was the highest ranked of the
four alternatives and thus was selected for the skin ￿ ange
component to be developed in combination with the
‘drawcord lantern’ retention mechanism as the ￿ nal
design for the SuPort Project (Fig. 4).
3.2 Manufacture
In July 1998, a decision was made regarding the optimal
material for the manufacture of the device that was to
prove crucial to the outcome of the project. Polyurethane
was selected in preference to the original plan to use
silicone. Polyurethane was considered to provide both a
greater diversity of hardness and ease of bonding, and
furthermore a reduced risk of surface encrustation.
When the manufacturing stage of the SuPort device was
Table 5 Ranked design alternatives
Merit
Feasible design function Ranking
Alternative 5 2.056 1
Alternative 3 1.223 2
Alternative 2 1.097 3
Alternative 6 1.038 4
Fig. 4 Final design of the suprapubic port302 R C L FENELEY, J PARKIN, J SCANLAN AND M WOOLLEY
reached, a series of problems began to emerge. In
January 2000, the toxicity tests on the adhesive selected
to ￿ x the drawstrings for the drawcord lantern were
unavailable. This information could not be included in
the dossier prepared on the device for submission to the
Medical Devices Agency (MDA), and an alternative
￿ xation method was developed using a stainless steel
collet. In March 2000, the application to the MDA was
rejected because of the lack of appropriate validation
data on the sterilization process for the port; the indus-
trial partner had based the validation on their experience
of the sterilization procedure used for Nelaton catheters.
A bioburden assay was thus undertaken following
sterilization of the suprapubic port by gamma radiation.
Injection moulding of the device commenced in June
2000, and the use of polyurethane presented problems.
Component shrinkage occurred during the process, and
tooling problems for moulding the skin ￿ange arose.
Information became available about the unstable
response of polyurethanes to manufacturing processes,
with batch-to-batch variation in polyurethane proper-
ties, sensitivity to thermal degradation and environmen-
tal stress and cracking. In November 2000, evidence was
produced that the polyurethanes that had been selected
(Chrono￿ ex-CL) required the use of a water-cooled
mould and 5 min cooling.
In view of the continuing delays with the manufacture
of the skin ￿ ange, and theoretical worries involving the
in vivo reliability of the retention mechanism, a decision
was made to focus on testing the e￿ ectiveness of the
drawstring lantern retention mechanism.
Therefore, slight modi￿ cations were made to allow
direct drainage from the device into a catheter drainage
system, and ￿ nally the product was manufactured in
early 2001. After a series of pretrial laboratory assess-
ments, which con￿ rmed that the devices functioned
appropriately in vitro, a clinical trial was performed.
3.3 Clinical trial
The clinical trial was to involve six patients, with the
device in place for variable periods of time, increasing
from 1 week for the ￿ rst patient to 6 weeks for the last.
After a period of analysis, a second trial was planned
when the device would be inserted for up to 12 weeks.
Ethical Committee approval and informed consent were
obtained. The clinical trial was terminated after the ￿ rst
four patients because of persistent leakage of urine from
the device after a few hours. Three devices were removed
after only 12–48 h, the drawstring lantern mechanism
apparently functioning satisfactorily, but the fourth
device was accidentally pulled out by the patient after
becoming unexpectedly disturbed.
The post-trial laboratory assessment concluded that
leakage of urine occurred from the skin ￿ ange owing to
a combination of two problems:
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1. A manufacturing error allowed direct communication
through the drawcord holes between the internal
lumen of the device and the external surface.
2. Creep of the polyurethane material a￿ ected the
watertight seal between the device and the drainage
tubes.
The SuPort Project ended in August 2001. Following the
foreshortened clinical trial, further design modi￿ cations
were made to address the de￿ ciencies identi￿ ed, but
there was no time to produce the ￿ nal device, subject it
to laboratory assessment or repeat the trial using the
modi￿ ed product.
4 CONCLUSIONS
The aim of this project was to design a novel suprapubic
bladder drainage device, and it was carried out by a
multidisciplinary team including engineers, industrial-
ists, clinicians and nurses. The inclusion of patients,
carers and community nursing sta￿ in discussions on
how the device should both look and function was con-
sidered important. Using QFD, their requirements were
placed alongside the ideas of the clinical team to become
the focus of product development. Although the
MedLINK project failed to produce alternative urine
collection systems, the design of the SuPort has been
patented, and an initial pilot study has been carried out
on the retention mechanism of the SuPort device. Also,
a considerable amount of information has been accumu-
lated from the studies, and many other goals have been
achieved.
These achievements include original research into the
anatomical and physiological properties of the supra-
pubic cystostomy tract, together with the design of a
model. The QFD exercise has produced a large volume
of requirements from patients and the medical team,
highlighting one of the de￿ ciencies of QFD: this amount
of information can become di￿ cult to interpret, or cause
problems, when there are con￿ icting customer require-
ments. The engineering unit has used the information
gathered to develop a new system that enhances QFD
and may address some of the de￿ ciencies of the current
model [20]. Finally, publications in nursing, clinical and
scienti￿ c journals have highlighted the clinical problems
associated with long-term catheterization, together with
the need for alternative urine collection systems [21–24].
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